Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Sector focus.
Global perspective. Cross border capabilities.


The reimbursement, regulatory and technological environments in this sector are constantly evolving. And demand for effective and affordable healthcare is driven by the aging global population. We are also looking at exciting potential returns from the increasing volume and quality of innovation.

That is one of the reasons why we launched a dedicated Healthcare and Technology practice in Nashville in 2015. By combining our global resources and local expertise, we provide innovative thinking and ideas to help you navigate this dynamic sector.

As a leading independent global investment bank, we offer a wide range of advisory and capital raising services as well as complex cross-border expertise to both emerging and established companies. Our idea-driven M&A & Financial Advisory, Equity Capital Markets, Debt Advisory & Restructuring and Financial Sponsors services are tailored to helping our clients achieve their strategic and financial goals.

Our clients are public and private healthcare companies from across all sub sectors. We have in-depth expertise across the following: 

  • Biopharmaceuticals
  • Cannabis
  • Diagnostics
  • HC Services
  • Med Tech

Thomas O’Connor joins Canaccord Genuity

Canaccord Genuity Bolsters U.S. Healthcare Investment Banking Leadership.

View full announcement here

Our Healthcare transactions

We have executed a number of deals over the last few years with a specific focus, in North America, on the MedTech and Diagnostics and Biopharma subsectors. See some of our recent transactions below:

Olema Pharmaceuticals, Inc.

November 2020


Equity Capital Markets


Stoke Therapeutics, Inc.

November 2020


Equity Capital Markets


Morgan Stanley Capital Partners



M&A Advisory


Accolade, Inc.

Co-Manager (Follow-on)
October 2020


Equity Capital Markets


= Cross-border transactions

Meet our Healthcare team

We believe in developing and nurturing long term client partnerships. Our Healthcare sector team is keen to explore new opportunities and can offer our clients access to global capital markets due to our expertise across multiple regions. That means we can offer our clients highly relevant services. Please get in touch if you’d like to find out more.


Photo of Jeff Barlow

Jeff Barlow

President, Canaccord Genuity LLC. (US)

Read more
Photo of Eugene Rozelman

Eugene Rozelman

Managing Director & Co-Head of U.S. Healthcare Investment Banking, Head of U.S. Biotech & Spec Pharma Investment Banking

Read more
Photo of Matt Steere

Matt Steere

Managing Director & Co-Head Healthcare Investment Banking, Medical Technologies & Diagnostics

Read more
Photo of Tom O'Connor

Tom O'Connor

Managing Director & Co-Head Healthcare Investment Banking

Read more



Photo of Daniel Sharp

Daniel Sharp

Executive Director, Corporate Finance

Read more

UK & Europe

Investment Banking

We have the independence and agility to offer clients sector-focused and idea-driven M&A Advisory, Equity Capital Markets, Debt Advisory and Restructuring and Financial Sponsors services.

Global locations

We have extensive operations in Asia, Australia, Canada, the Middle-East, the UK & Europe and the US. 

Our events

Discover our upcoming events around the world.


Our analysts have in-depth knowledge and offer unique, informed insights that clients can access through our research portal.

Our sector coverage includes:

  • Biomedical Devices and Services
  • Biotechnology
  • Cannabis
  • Diagnostics and Tools
  • Healthcare IT
  • Healthcare Services
  • Pharmaceuticals
  • Veterinary Services



Sales & Trading

We provide access to global capital markets, connecting the right idea with the right client at the right time through our experienced team.

Corporate Access & Conferences

We have the contacts and expertise to help you find the right investors to speak to.


Enjoy key investment insights from Quest®, our innovative online platform or get help, advice and support directly from our research and sales teams.


Our dedicated team ensured that all of our business areas that were affected by MiFID II / MiFIR were prepared for the 3rd of January.

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.

Back to top